nitrates has been researched along with Hematochezia in 21 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Hematochezia: The passage of bright red blood from the rectum. The blood may or may not be mixed with formed stool in the form of blood, blood clots, bloody stool or diarrhea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on low-certainty evidence, beta-blockers, variceal band ligation, sclerotherapy, and beta-blockers plus nitrates may decrease mortality compared to no intervention in people with high-risk oesophageal varices in people with cirrhosis and no previous history of bleeding." | 5.12 | Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021) |
| "About 15% to 20% of oesophageal varices bleed in about one to three years of diagnosis." | 2.72 | Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Fritche, D; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021) |
| "About 15% to 20% of oesophageal varices bleed within about one to three years after diagnosis." | 2.72 | Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Milne, EJ; Pavlov, CS; Roberts, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Walshaw, D; Williams, NR, 2021) |
| "Recent advances in the pharmacologic treatment of portal hypertension have mainly focused on modifying an increased intrahepatic resistance through nitric oxide and/or modulation of vasoactive substances." | 2.61 | Pharmacologic Management of Portal Hypertension. ( Bunchorntavakul, C; Reddy, KR, 2019) |
| "In conclusion, chronic administration of organic nitrates, allowing for a nitrate-free interval each day, to cirrhotic patients reduces portal pressure with a variable, dose-dependent effect on azygos blood flow." | 2.39 | Organic nitrates in portal hypertension. ( Hayes, PC; Jones, AL, 1994) |
| "The pharmacologic treatment of portal hypertension should be able to stop as well as to prevent variceal hemorrhage." | 2.38 | Pharmacologic treatment of portal hypertension. ( Groszmann, RJ; Rodríguez-Pérez, F, 1992) |
| "Symptoms of painful dysphagia after intake of an "unknown" liquid party drug should raise the suspicion of an accidental oral ingestion of Poppers." | 1.42 | [Partynight outcome]. ( Lock, G; Oelckers, M; Wunder, AF, 2015) |
| "The prevalence of large esophageal varices was 20%." | 1.30 | Predictors of large esophageal varices in patients with cirrhosis. ( Boyer, TD; Carey, M; Chalasani, N; Imperiale, TF; Ismail, A; Kwo, PY; Madichetty, H; Sood, G; Wilcox, CM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bunchorntavakul, C | 1 |
| Reddy, KR | 1 |
| Plaz Torres, MC | 2 |
| Best, LM | 3 |
| Freeman, SC | 3 |
| Roberts, D | 3 |
| Cooper, NJ | 3 |
| Sutton, AJ | 3 |
| Roccarina, D | 2 |
| Benmassaoud, A | 2 |
| Iogna Prat, L | 2 |
| Williams, NR | 3 |
| Csenar, M | 3 |
| Fritche, D | 1 |
| Begum, T | 3 |
| Arunan, S | 3 |
| Tapp, M | 3 |
| Milne, EJ | 3 |
| Pavlov, CS | 3 |
| Davidson, BR | 3 |
| Tsochatzis, E | 3 |
| Gurusamy, KS | 3 |
| Walshaw, D | 1 |
| Mustafa, MZ | 1 |
| Stanley, A | 1 |
| Wunder, AF | 1 |
| Oelckers, M | 1 |
| Lock, G | 1 |
| Lin, KJ | 1 |
| Hernández-Díaz, S | 1 |
| García Rodríguez, LA | 1 |
| Augustin, S | 1 |
| González, A | 1 |
| Badia, L | 1 |
| Millán, L | 1 |
| Gelabert, A | 1 |
| Romero, A | 1 |
| Segarra, A | 1 |
| Martell, M | 1 |
| Esteban, R | 1 |
| Guardia, J | 2 |
| Genescà, J | 1 |
| McCarty, MF | 1 |
| Targownik, LE | 1 |
| Spiegel, BM | 1 |
| Dulai, GS | 1 |
| Karsan, HA | 1 |
| Gralnek, IM | 1 |
| Rockey, DC | 1 |
| Wallace, JL | 1 |
| Jones, AL | 1 |
| Hayes, PC | 1 |
| Lebrec, D | 1 |
| Chalasani, N | 1 |
| Imperiale, TF | 1 |
| Ismail, A | 1 |
| Sood, G | 1 |
| Carey, M | 1 |
| Wilcox, CM | 1 |
| Madichetty, H | 1 |
| Kwo, PY | 1 |
| Boyer, TD | 1 |
| Lanas, A | 1 |
| Bajador, E | 1 |
| Serrano, P | 1 |
| Fuentes, J | 1 |
| Carreño, S | 1 |
| Sanz, M | 1 |
| Montoro, M | 1 |
| Sáinz, R | 1 |
| Angelico, M | 1 |
| Lionetti, R | 1 |
| Landmark, K | 1 |
| Vogt, W | 1 |
| Rodríguez-Pérez, F | 1 |
| Groszmann, RJ | 1 |
| Fleig, WE | 1 |
13 reviews available for nitrates and Hematochezia
| Article | Year |
|---|---|
Pharmacologic Management of Portal Hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anticoagulants; Antihypertensi | 2019 |
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Topics: Adrenergic beta-2 Receptor Antagonists; Adult; Bias; Esophageal and Gastric Varices; Gastrointestina | 2021 |
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Topics: Adrenergic beta-Antagonists; Bias; Combined Modality Therapy; Drug Therapy, Combination; Esophageal | 2021 |
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Topics: Adult; Bayes Theorem; Bias; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointesti | 2021 |
Variceal rebleeding: use of drug therapy and endoscopic band ligation.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Gastro | 2014 |
Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.
Topics: Adrenergic beta-Antagonists; Algorithms; Antihypertensive Agents; Cardiovascular Agents; Esophageal | 2006 |
Nitric oxide, aspirin-triggered lipoxins and NO-aspirin in gastric protection.
Topics: Acetylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Gastric Mu | 2006 |
Organic nitrates in portal hypertension.
Topics: Animals; Collateral Circulation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans | 1994 |
Review: pharmacotherapeutic agents in the treatment of portal hypertension.
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Forecasting; Gastrointestinal Hemorrhag | 1997 |
Long-acting nitrates in portal hypertension: to be or not to be?
Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Esophageal and Gastric Varices; Female; Ga | 2001 |
[The patient with hematemesis. What to do?].
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Electrocoagulation; Emergencies; Endos | 2002 |
Pharmacologic treatment of portal hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Clonidine; Gastrointestinal Hemorrha | 1992 |
Pharmacological methods for the prevention of first and recurrent bleeding from esophagogastric varices.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Esophageal and Gastric Varices; Gastrointesti | 1988 |
8 other studies available for nitrates and Hematochezia
| Article | Year |
|---|---|
[Partynight outcome].
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Deglutition Disorders; Dilatation; Eso | 2015 |
Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Female; Fibrinolytic | 2011 |
Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; | 2012 |
Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Catechin; Gastric Mucosa; Gastrointestinal Hemorr | 2013 |
The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Blood Pressure Determination; Cost-Benefit Analysis; Endoscopy, Digesti | 2004 |
Predictors of large esophageal varices in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Cohort Studies; Confidence Intervals; Cost-Benefit Analysis; Costs and | 1999 |
Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Drug Interactions; Dru | 2000 |
[Do nitrates reduce the risk of drug induced hemorrhage of the upper gastrointestinal tract?].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Humans; Isos | 2001 |